Workflow
Veralto
icon
Search documents
Veralto (VLTO) - 2025 Q3 - Earnings Call Presentation
2025-10-29 12:30
Q3 2025 Financial Performance - Sales increased by 6.9% year-over-year, reaching $1.404 billion[18] - Core sales growth was +5.1%, driven by volume (+2.7%) and price (+2.4%)[8] - Adjusted EPS increased by 11.2% year-over-year to $0.99[8, 18] - Free cash flow reached $258 million, representing a 108% free cash flow conversion[8, 20] - Adjusted EBITDA margin was 24.7%[8] - Adjusted operating profit margin was 23.9%, a decrease of 20 basis points year-over-year[8, 18] Segment Performance - Water Quality sales increased to $856 million, with core growth of +5.3%[23] and adjusted operating profit increased by 13.1%[26] - Product Quality & Innovation sales increased to $548 million, with core growth of +4.6%[31] and adjusted operating profit decreased by 2.1%[34] Geographic Performance - North America core sales grew by +6.9% in Q3 2025[11] - Western Europe core sales grew by +2.5% in Q3 2025[11] - High Growth Markets core sales grew by +4.3% in Q3 2025[11] FY2025 Guidance - The company expects mid-single-digit core sales growth for the full year 2025[40, 41] - Adjusted EPS is projected to be between $3.82 and $3.85[40] - Free cash flow conversion is expected to be approximately 100%[40]
“并购之王”丹纳赫是如何“养成”的?
首席商业评论· 2025-09-26 05:21
Core Insights - Danaher Corporation has successfully completed nearly 400 acquisitions over 40 years, spending approximately $90 billion, resulting in a market capitalization of about $200 billion and creating around $250 billion in shareholder value [2][4] - The company achieved an average annual return of 22% over the past 40 years, outperforming the S&P 500's 12% and Berkshire Hathaway's 16% during the same period [2] Acquisition Characteristics - High Frequency: Danaher averages over 10 acquisitions per year, with a peak of 19 in one year, never recording a year without acquisitions [4] - High Success Rate: While 70% to 90% of acquisitions in the market fail, Danaher's major acquisitions, such as those of Fluke and Beckman Coulter, have been largely successful [4] - Cross-Industry: The company has successfully operated across various industries, from low-end manufacturing to advanced life sciences and diagnostics [4] Evolution of Acquisition Style - In the 1980s, Danaher focused on high leverage and significant asset restructuring, later shifting to a strategy of seeking innovative, low-cost products in niche markets [6] - Under CEO Kalp, a world-class core team was established, leading to a more scientific and structured acquisition process, integrating the Danaher Business System (DBS) into acquisition management [7][8] Recent Trends in Acquisitions - Post-2016, Danaher has focused on divesting non-core businesses and concentrating on life sciences and diagnostics, with over 95% of acquisition funds directed towards these sectors [11][12] - The average number of acquisitions per year decreased to 7.4, but the average deal size increased to $910 million, with total spending exceeding $60 billion [12] - The company has also begun early-stage technology investments, establishing a venture capital arm to identify disruptive technologies in the life sciences sector [14] Platform Strategy - Danaher has successfully established strategic platforms, such as water quality and testing measurement, through foundational acquisitions followed by complementary acquisitions to enhance market presence [16][22] - The water quality platform has seen significant growth, with revenues increasing from $500 million in 2002 to $2.9 billion in 2022, achieving a return on invested capital (ROIC) exceeding 20% [21] - The testing measurement platform, which included the acquisition of Fluke and Tektronix, generated substantial returns and contributed to Danaher's reputation for successful acquisitions [23] Sector-Specific Insights - The life sciences platform has become a key focus, with significant investments and acquisitions aimed at enhancing capabilities in diagnostics and biopharmaceuticals [42] - The in vitro diagnostics platform has been particularly successful, with revenues reaching $9.6 billion and an operating profit margin of 27.4% [38][41] - The dental technology platform faced challenges post-acquisition, leading to its eventual spin-off, highlighting the complexities of integration in certain sectors [36][33]
Veralto (VLTO) - 2025 Q1 - Earnings Call Presentation
2025-04-30 01:01
First Quarter 2025 Results April 29, 2025 Forward Looking Statements Certain statements in this presentation, including statements regarding the Company's second quarter and full year 2025 financial performance and guidance, the Company's differentiation and positioning to continue delivering sustainable, long-term shareholder value and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of th ...